Utah Medical Products Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 22 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Consolidated Sales Growth (Constant Currency) Quarterly-1,190.0%Target: Stabilization / Positive Growth
Gross Profit Margin Quarterly6,060.0%Target: Maintain > 55%
Operating Income Margin Quarterly2,940.0%Target: Maintain > 30%
Watch Items
- Filshie Clip Product Liability LitigationTrigger: Any unfavorable trial verdict or failure to dismiss remaining cases in CT state courtAction: Re-evaluate legal reserve provisions and potential long-term impact on the gynecology franchise.
- OUS Distributor Sales RecoveryTrigger: Persistent double-digit declines in OUS sales beyond Q2 2026Action: Assess distributor performance, contract terms, and regulatory compliance costs under EU MDR.
Research as of 20 Jun 2026